Ameritas Investment Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,166
| Closed | -$81.3K | – | 3282 |
|
|
2024
Q1 | $81.3K | Hold |
5,166
| – | – | ﹤0.01% | 1865 |
|
|
2023
Q4 | $83.3K | Hold |
5,166
| – | – | ﹤0.01% | 1860 |
|
|
2023
Q3 | $65.7K | Buy |
5,166
+1,017
| +25% | +$14K | ﹤0.01% | 1933 |
|
|
2023
Q2 | $58.4K | Hold |
4,149
| – | – | ﹤0.01% | 1952 |
|
|
2023
Q1 | $64.1K | Buy |
4,149
+844
| +26% | +$14.1K | ﹤0.01% | 1821 |
|
|
2022
Q4 | $59K | Hold |
3,305
| – | – | ﹤0.01% | 1951 |
|
|
2022
Q3 | $61K | Hold |
3,305
| – | – | ﹤0.01% | 1837 |
|
|
2022
Q2 | $43K | Hold |
3,305
| – | – | ﹤0.01% | 2093 |
|
|
2022
Q1 | $31K | Hold |
3,305
| – | – | ﹤0.01% | 2354 |
|
|
2021
Q4 | $32K | Hold |
3,305
| – | – | ﹤0.01% | 2411 |
|
|
2021
Q3 | $112K | Hold |
3,305
| – | – | ﹤0.01% | 1614 |
|
|
2021
Q2 | $121K | Hold |
3,305
| – | – | ﹤0.01% | 1606 |
|
|
2021
Q1 | $148K | Hold |
3,305
| – | – | 0.01% | 1410 |
|
|
2020
Q4 | $189K | Hold |
3,305
| – | – | 0.01% | 1194 |
|
|
2020
Q3 | $170K | Hold |
3,305
| – | – | 0.01% | 1116 |
|
|
2020
Q2 | $197K | Buy |
3,305
+1,609
| +95% | +$86.1K | 0.01% | 1031 |
|
|
2020
Q1 | $70K | Buy |
1,696
+120
| +8% | +$6.66K | ﹤0.01% | 1474 |
|
|
2019
Q4 | $98K | Hold |
1,576
| – | – | ﹤0.01% | 1533 |
|
|
2019
Q3 | $53K | Buy |
1,576
+301
| +24% | +$8.91K | ﹤0.01% | 1857 |
|
|
2019
Q2 | $29K | Buy |
1,275
+575
| +82% | +$13.5K | ﹤0.01% | 2229 |
|
|
2019
Q1 | $16K | Hold |
700
| – | – | ﹤0.01% | 2495 |
|
|
2018
Q4 | $15K | Hold |
700
| – | – | ﹤0.01% | 2500 |
|
|
2018
Q3 | $27K | Hold |
700
| – | – | ﹤0.01% | 2364 |
|
|
2018
Q2 | $28K | Hold |
700
| – | – | ﹤0.01% | 2324 |
|
|
2018
Q1 | $14K | Hold |
700
| – | – | ﹤0.01% | 2607 |
|
|
2017
Q4 | $16K | Buy |
+700
| New | +$13.7K | ﹤0.01% | 2561 |
|
Other funds holding DCPH
Ameritas Investment Partners's DCPH Position: Q2 2024 in Review
Ameritas Investment Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 5,166 shares — an estimated $81.3K sold.
Ameritas Investment Partners first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $197K in Q2 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Ameritas Investment Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Ameritas Investment Partners sold 5,166 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $81.3K.
- Ameritas Investment Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
- Ameritas Investment Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $197K in Q2 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.